Coronary Physiology in Diffuse Disease: Update on Clinical Evidence and Daily Practice
Diffuse disease: Who is most affected by this coronary pathology? What are the main causes behind it? How to treat it?
Join this webinar to listen to our panel of international experts!
They will provide an update on the latest clinical evidence, share their experience on the decision-making process in patients with diffuse disease to debate and eventually agree on the role of coronary physiology in driving their PCI strategy.
Clinical cases will be the center of the discussion to understand, assess, challenge and endorse the different technological solutions physicians can use today to optimize their interventions.
For more information, please visit the Opsens Medical website, here.
Evald Høj Christiansen
This broadcast is supported by:
Welcome and Introduction
Overview on which clinical evidence drives today’s interventional strategy
Daily Practice Experience
Presentation of two patient cases highlighting the role of physiology in the decision-making process of the Experts
New study outcomes and approaches to optimize the interventional strategy
- To listen to the debate on the interventional strategy in patients with diabetes and hyperlipidaemia
- To learn about different techniques to assess diffuse disease and decide how to treat (long lesions, tandem, etc…)
- To get an update on the current clinical evidence supporting physicians in their decision making
- To review the patients case reported by the Cardiology Experts in their practice
- Interventional cardiologists
Dr Hitoshi Matsuo is currently President of Gifu Heart Center, and Clinical Visiting Professor of Medicine in Gifu University School of Medicine. He graduated from Jichi Medical School in 1986. He spent one year at Johns Hopkins Medical Institutions in Baltimore as a research fellow of Nuclear Medicine from 1987. He dedicated his clinical research work on physiology and interventional cardiology using pressure guide wires at Gifu Prefectural General Medical Center, Toyohashi Heart Center and Gifu Heart Center. Dr Matsuo is now participating in and contributing to many international multi-center trials including DEFINE-FLAIR, international multicenter FFRCT registry (ADVANCE registry), 3V-FFR FRIENDS study, DEFINE FLOW study and FAVOR2 Europe and Japan.
Evald Høj Christiansen
Dr Evald Høj Christiansen is an Associate Professor in the Cardiology Department of Aarhus University Hospital. He is an interventional cardiologist with 15 years' of experience in the field. His main interest is chronic total occlusions, bifurcations, coronary imaging, physiologic evaluations of coronary artery disease, and TAVR. He has performed a series of studies in this area and has conducted many clinical trials.
Dr Kovarnik is Head of the Invasive Cardiology Department from 2015 and Associated Professor of Internal Medicine at the Charles University in Prague (Czech).
He is also member of National (Czech) and International medical societies, co-inventor of patent and reviewer of several international journals.
Dr. Kovarnik main field of interest are in development and regression of coronary atherosclerosis, plaque risk features, coronary physiology, invasive coronary imaging modalities, TAVI and acute cardiac care.
Dr Zsolt Piroth is an interventional cardiologist, and serves as Deputy Head of the Adult Cardiology Department of the György Gottsegen Hungarian Institute of Cardiology, Hungary. A Fellow of the European Society of Cardiology, he is the Secretary of the Intensive Working Group of the Hungarian Society of Cardiology and was Vice-Chair of the Interventional Working Group of the Hungarian Society of Cardiology.